Product Images Olanzapine

This text contains prescribing information of a medication whose usual dosage is not mentioned. Each tablet contains a specific NDC code and must be kept out of reach of children. The tablets should be stored at 20° or USP controlled room temperature in light-resistant containers. The medication must be protected from light and moisture. The bottle should not be opened until immediately prior to use. The medication contains phenyllanine, a component of aspartame. The manufacturer is Mylan Pharmaceuticals Inc, and the medication is packaged in a bottle containing 30 tablets manufactured in India. The text also provides a prompt for LOT and EXP numbers to be printed along with variable data online coding wherever applicable.*

Each tablet contains 10mg of Olanzapine, USP. The usual dosage must be checked in the accompanying prescribing information. The medication needs to be kept away from children, and protected from light and moisture. It is manufactured by Mylan Pharmaceuticals Inc., USA, and made in India. The orally-disintegrating tablets must be dispensed in a tight, light-resistant, child-resistant container, and kept tightly closed. The medication guide must be given to each patient. The tablets contain phenyllarine, which is a component of aspartame. The details of LOT, EXP, SNO, and GTIN will be printed, wherever applicable.*

This is a medication packaging for Olanzapine tablets in 15mg dosage. The tablet pack contains 30 tablets and is identifiable using the NDC number NoG 0578-5512.00. Usual dosage instructions are not available and should be obtained from the attached instructions. Additionally, the tablet should be kept in a cool, dry place and protected from both light and moisture. The tablet pack also warns not to open the bottle until just before it's about to be used. Finally, the medication should be kept away from children in a tightly-lidded light-resistant container.*

This is a medication containing 20mg of Olanzapine in tablet form. Usual dosage can be found in the accompanying prescribing information. It must be stored at 20°C to 25°C, protected from light and moisture. The bottle should not be opened until immediately prior to use. The medication guide must be given to each patient, and it contains a phenylalanine component. The tablets have passed USP Disintegration Test 2 and should be dispensed in a tight, light-resistant container with a child-resistant closure. The lot number and expiry date will be printed along with variable data coding. It is manufactured for Mylan Pharmaceuticals Inc, with the drug's source as India.*